TMS is needed in Public Mental Health Services
Open Access
- 30 October 2025
- journal article
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 34 (1) , 17-19
Abstract
Transcranial magnetic stimulation (TMS) is essential for the comprehensive treatment of major depressive disorder (MDD). Around Australia, it is widely available in private practice, but in few Public Mental Health Services. TMS is a revolutionary treatment. Using electromagnetic apparatus, the function of precise local and distant regions of the brain can be modulated, with minimal side effects. Half of patients with MDD do not respond to antidepressant medication. However, a large proportion of medication non-responders can be brought to remission using TMS. This intervention is cost-effective and availability in public practice should be increased.Keywords
This publication has 15 references indexed in Scilit:
- A cross-sectional study on the relationship between cardiorespiratory fitness, inhibitory control, and event-related potentials moderated by severity of symptoms in patients with major depressive disorderJournal of Affective Disorders, 2025
- Brain connectivity and transcriptional changes induced by rTMS in first-episode major depressive disorderTranslational Psychiatry, 2025
- Cost‐Effectiveness of rTMS as a Next Step in Antidepressant Non‐Responders: A Randomized Comparison With Current Antidepressant Treatment ApproachesActa Psychiatrica Scandinavica, 2024
- Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical NeurophysiologyClinical Neurophysiology, 2024
- Should rTMS be considered a first-line treatment for major depressive episodes in adults?Clinical Neurophysiology, 2024
- Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depressionJournal of Affective Disorders, 2024
- Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic StimulationJournal of Affective Disorders, 2020
- Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive DisorderArchives of General Psychiatry, 2010
- Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled TrialBiological Psychiatry, 2007
- Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depressionThe Lancet, 1996